Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wasnaire

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|November 16, 2007
Intramolecular Stetter cyclisation of Morita-Baylis-Hillman adducts: a versatile approach towards bicycloenedionesPierre Wasnaire, Thierry de Merode, István E Markó
The Journal of Organic Chemistry|September 29, 2009
Synthesis of the louisianin alkaloid family via a 1,2,4-triazine inverse-electron-demand Diels-Alder approachNicola Catozzi, Michael G Edwards, Steven A Raw, et al.
European Journal of Heart Failure|September 18, 2020
Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failureThomas Mondritzki, Thuy Anh Mai, Julia Vogel, et al.
Journal of Cardiovascular Pharmacology|July 6, 2019
Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor AntagonistPeter Kolkhof, Elisabeth Pook, Mira Pavkovic, et al.
Journal of Medicinal Chemistry|February 13, 2024
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 InhibitorDaniel Meibom, Pierre Wasnaire, Kristin Beyer, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|November 16, 2007
Intramolecular Stetter cyclisation of Morita-Baylis-Hillman adducts: a versatile approach towards bicycloenedionesPierre Wasnaire, Thierry de Merode, István E Markó
The Journal of Organic Chemistry|September 29, 2009
Synthesis of the louisianin alkaloid family via a 1,2,4-triazine inverse-electron-demand Diels-Alder approachNicola Catozzi, Michael G Edwards, Steven A Raw, et al.
European Journal of Heart Failure|September 18, 2020
Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failureThomas Mondritzki, Thuy Anh Mai, Julia Vogel, et al.
Journal of Cardiovascular Pharmacology|July 6, 2019
Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor AntagonistPeter Kolkhof, Elisabeth Pook, Mira Pavkovic, et al.
Journal of Medicinal Chemistry|February 13, 2024
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 InhibitorDaniel Meibom, Pierre Wasnaire, Kristin Beyer, et al.
Pageof 1